irinotecan has been researched along with aphidicolin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hapke, G; Rustum, YM; Tóth, K; Wu, J; Yin, MB | 1 |
| Almasan, A; Fraizer, GC; Ray, S; Shyam, S | 1 |
2 other study(ies) available for irinotecan and aphidicolin
| Article | Year |
|---|---|
Induction of biphasic DNA double strand breaks and activation of multiple repair protein complexes by DNA topoisomerase I drug 7-ethyl-10-hydroxy-camptothecin.
Topics: Aphidicolin; Apoptosis; Camptothecin; Cell Division; DNA Damage; DNA Fragmentation; DNA Ligases; DNA Repair; DNA Topoisomerases, Type I; Drug Interactions; Electrophoresis, Gel, Pulsed-Field; Enzyme Activation; Enzyme Inhibitors; Humans; Irinotecan; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2002 |
S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aphidicolin; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Camptothecin; Cell Cycle Proteins; Cell Line, Tumor; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA-Binding Proteins; Down-Regulation; Drug Synergism; Enzyme Activation; Humans; Irinotecan; Ligands; Male; Mice; Prostatic Neoplasms; Protein Kinases; Protein Serine-Threonine Kinases; Receptors, TNF-Related Apoptosis-Inducing Ligand; S Phase; TNF-Related Apoptosis-Inducing Ligand; Transplantation, Heterologous; Tumor Suppressor Proteins | 2007 |